Riverwater Partners, an investment management company, released its “Small Cap Strategy” Q3 2025 investor letter. A copy of ...
The Personal Finance Society (PFS) has announced that over 400 individuals have so far expressed interest in the PFS Pathway ...
More than 400 individuals have expressed interest in the PFS Pathway to the Profession initiative. Launched in July, the ...
GMA News Online on MSN
DOH eyes safeguards vs high doctors’ fees
The Department of Health (DOH) said on Saturday it is studying reforms to protect patients from exorbitant professional fees ...
MedPage Today on MSN
Overcoming CDK4/6 Inhibitor Resistance in HR-Positive/HER2-Negative Breast Cancer
In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...
CEO.CA ("CEO.CA"), the leading investor social network in junior resource and venture stocks, shares exclusive updates with ...
“For many years, the standard of care for ASHL was based on the RATHL trial, where newly diagnosed patients were given two cycles of ABVD [doxorubicin, bleomycin, vinblastine, and dacarbazine] and ...
Major Technical Breakthrough Highlights Rare earth oxides were produced from Halleck Creek ore using the updated preliminary ...
Magna Mining Inc. (TSXV: NICU) (OTCQX: MGMNF) (FSE: 8YD) (“Magna” or the “Company”) is pleased to announce that Technica ...
Detailed price information for Provident Financial Services (PFS-N) from The Globe and Mail including charting and trades.
CEO.CA ("CEO.CA"), the leading investor social network in junior resource and venture stocks, shares exclusive updates with CEOs of junior mining ...
Clinical Trials Arena on MSN
Daiichi Sankyo announces first patient dosed in phase III trial of Enhertu
Daiichi Sankyo has announced the dosing of first patient in the DESTINY-Ovarian01 Phase III trial’s randomisation phase, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback